Hub Cyber Security Ltd. has scheduled a Special General Meeting of Shareholders for December 9, 2026. This meeting is significant as it will provide shareholders the opportunity to vote on critical matters that could shape the company's future. The timing of this meeting comes as the company continues to navigate the competitive landscape of the Computer Communications Equipment sector.
Background
Hub Cyber Security Ltd. operates in the Computer Communications Equipment industry, as classified under the SIC code 3576. The company is listed on the Nasdaq under the tickers HUBC, HUBCW, and HUBCZ. Recent filings indicate that Hub Cyber Security is classified as a non-accelerated filer and an emerging growth company.
What the Filing Says
According to the recent filing dated November 18, 2026, the company has published a notice regarding the upcoming Special General Meeting. The proxy statement attached to the filing outlines the agenda for the meeting and encourages shareholders to participate in the voting process. The filing states, "HUB’s board of directors unanimously recommends that you vote ‘FOR’ each proposal set forth in the Notice." This emphasizes the board's confidence in the proposals being presented.
Impact
The outcome of the Special General Meeting may have significant implications for shareholders and the company's strategic direction. Stakeholders will be keen to understand how the decisions made during this meeting could affect Hub Cyber Security's position in the rapidly evolving Computer Communications Equipment industry. The meeting will also be an opportunity for shareholders to express their views and influence the company's future initiatives.
What's Next
The Special General Meeting is set to take place on December 9, 2026, at the company’s offices in Or Yehuda, Israel. Shareholders are encouraged to review the proxy statement and participate in the voting process. Further details regarding the outcomes of the meeting will likely be disclosed in subsequent filings.
Read Next
Alps Group Regains Compliance with Nasdaq Listing Standards
Ainos, Inc. Receives Nasdaq Delisting Notice Over Equity
Compass Therapeutics Receives Nasdaq Deficiency Notice
60 Degrees Pharmaceuticals Faces Nasdaq Delisting Risk
Biofrontera Inc. Faces Nasdaq Delisting Due to Low Stock Price
Senti Biosciences dismisses KPMG, appoints new auditor KNAV










